Last reviewed · How we verify

NCT07389889

Percutaneous Robotic Navigation Microwave Ablation Versus CT-guided Microwave Ablation in the Treatment of Pulmonary Nodules With Ground-glass Opacity

Not yet recruiting NA Last updated 5 February 2026
What this trial tests

NA trial testing Robot in Pulmonary Nodules in 116 participants. Not yet recruiting.

Timeline
1 February 2026
Primary endpoint
1 February 2028
1 February 2029

Quick facts

Lead sponsorFujian Medical University Union Hospital
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment116
Start date1 February 2026
Primary completion1 February 2028
Estimated completion1 February 2029

Drugs / interventions tested

Conditions studied

Sponsor

Fujian Medical University Union Hospital

Who can join

Adults 18 to 85, any sex, with Pulmonary Nodules or Ground-glass Opacity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

1. To compare the precision of robot-guided microwave ablation and CT-guided microwave ablation in the treatment of ground-glass nodules. 2. To evaluate the safety of robot-assisted microwave ablation and CT-guided microwave ablation in the treatment of ground-glass nodules. 3. Explore the application potential of robot navigation microwave ablation technology in the treatment of pulmonary nodules.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Robot

Trials testing the same drug.

Other recruiting trials for Pulmonary Nodules

Currently open trials in the same condition.

Other Fujian Medical University Union Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07389889.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing